Alt
/content/dam/asset-migration/headshots/au-doctor-headshots/AU_Oncology_Headshot_GA_Dr Nadine Beydoun.jpg

Dr Nadine Beydoun

Dr Nadine Beydoun
MBBS, FRANZCR, Radiation Oncologist

Languages spoken

English, Arabic

Overview

Centres

Hurstville (Oncology)
Hurstville (Oncology)
-33.96416762029818, 151.1004695691989
/au/our-centres/hurstville

Specialises in

Breast cancer
Condition
Condition/Cancer
Condition/Cancer/Breast Cancer
Gastrointestinal cancer
Condition
Condition/Cancer
Condition/Cancer/Gastrointestinal Cancer
Genitourinary cancer
Condition
Condition/Cancer
Condition/Cancer/Genitourinary Cancer
Lung cancer
Condition
Condition/Cancer
Condition/Cancer/Lung Cancer
Prostate cancer
Condition
Condition/Cancer
Condition/Cancer/Prostate Cancer
Skin cancer
Condition
Condition/Cancer
Condition/Cancer/Skin Cancer

Treatments

Prostate cancer spacers
Service
Service/Cancer
Service/Cancer/Radiation Oncology
Service/Cancer/Radiation Oncology/Prostate Cancer Spacers
Radiation therapy
Service
Service/Cancer
Service/Cancer/Radiation Oncology
Service/Cancer/Radiation Oncology/Radiation Therapy
Stereotactic ablative/body radiation therapy (SABR/SBRT)
Service
Service/Cancer
Service/Cancer/Radiation Oncology
Service/Cancer/Radiation Oncology/Stereotactic Ablative Radiation Therapy

Special clinical interest in urological, gastrointestinal, skin, lung, body stereotactic (SABR) and cranial stereotactic (SRS).

Dr Beydoun is a Fellow of The Royal Australian and New Zealand College of Radiologists (Faculty of Radiation Oncology). She obtained her Bachelor of Medicine from the University of New South Wales in 2004. Her interest in Oncology commenced during her years as a medical officer at Bankstown Hospital, which propelled her to complete her training in radiation oncology at the St George Hospital. She then undertook her subspecialty training in genitourinary cancer and brachytherapy at the St George Hospital Prostate cancer Institute (2012, 2013), with completion of hundreds of prostate brachytherapy implants, and publications on the use of Iodine-125 thinseeds, exercise intervention and hormonal therapy in prostate cancer patients, and polyethylene glycol hydrogel spacer use to ameliorate rectal toxicity in prostate radiotherapy.

She has presented her research internationally, including at The American Brachytherapy Society Meeting (New Orleans) in 2013, and undertaken an observership at the Memorial Sloan Kettering Cancer Centre in New York (2013). She became a Radiation Oncology Staff Specialist at Wollongong Hospital in 2013, and thereafter returned to St George Hospital as a Radiation Oncologist (2014-present).

Dr Beydoun is a member of the America Brachytherapy Society, the Australasian Brachytherapy Group, and The European Society for Therapeutic Radiation Oncology. She joined Genesis Cancer Care in 2015. Her interest sites include genitourinary, breast, gastrointestinal, lung, and gynaecological malignancies.